DHA-clozapine
DHA-clozapine[edit | edit source]
DHA-clozapine is a derivative of the atypical antipsychotic drug clozapine, which is modified by the addition of a docosahexaenoic acid (DHA) moiety. This modification is intended to enhance the pharmacological properties of clozapine, potentially improving its efficacy and reducing its side effects.
Chemical Structure[edit | edit source]
DHA-clozapine is characterized by the attachment of a docosahexaenoic acid chain to the clozapine molecule. The chemical structure of DHA-clozapine is depicted in the adjacent image. This structural modification is designed to leverage the neuroprotective and anti-inflammatory properties of DHA, a long-chain omega-3 fatty acid.
Mechanism of Action[edit | edit source]
The mechanism of action of DHA-clozapine is thought to involve both the traditional pathways associated with clozapine and additional pathways influenced by DHA. Clozapine primarily acts as an antagonist at dopamine D2 and serotonin 5-HT2A receptors, which contributes to its antipsychotic effects. The incorporation of DHA may enhance these effects by modulating neurotransmitter systems and reducing neuroinflammation.
Potential Benefits[edit | edit source]
The addition of DHA to clozapine is hypothesized to offer several potential benefits:
- Enhanced Efficacy: DHA may improve the therapeutic effects of clozapine by enhancing its action on neurotransmitter systems.
- Reduced Side Effects: The anti-inflammatory properties of DHA could mitigate some of the side effects associated with clozapine, such as metabolic syndrome and cardiovascular issues.
- Neuroprotection: DHA is known for its neuroprotective properties, which may help in preserving cognitive function in patients undergoing treatment.
Clinical Applications[edit | edit source]
While DHA-clozapine is still under investigation, it holds promise for the treatment of schizophrenia and other psychotic disorders. The combination of clozapine's antipsychotic properties with DHA's neuroprotective effects could provide a novel therapeutic option for patients who are resistant to traditional antipsychotic medications.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
